A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous t-cell lymphomas

Archives of Dermatology

Volumn 135, Issue 11, 1999, Pages 1349-1353

  Estève, Eric ^a   Bagot, Martine ^b   Joly, Pascal ^b   Souteyrand, Pierre ^b   Beylot Barry, Marie ^b   Vaillant, Loic ^b   Delaunay, Michèle ^b   Avril, Marie Françoise ^b   Laroche, Liliane ^b   Grange, Florent ^b   Thomine, Elisabeth ^b   Wechsler, Janine ^b  

^a Hôpital Porte Madeleine   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; CHLORMETHINE DERIVATIVE;

ADULT; AGED; ARTICLE; DISEASE CLASSIFICATION; FEMALE; HISTIOCYTOSIS X; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN ALLERGY; SKIN BIOPSY; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0344822638     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.11.1349     Document Type: Article

References (26)

1. Ramsay DL, Parnes RE, Dubin N. Response of mycosis fungoides to topical chemotherapy with mecblorethamine. Arch Dermatol. 1984;120:1585-1590.
2. Ramsay DL, Halperin PS, Zeleniuch-Jacquotte A. Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol. 1988;19: 684-691.
3. Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9:1031-1056.
4. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage lA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis. Arch Dermatol. 1996;132:1309-1313.
5. Bunn PA Jr. Rational therapy for cutaneous T-cell lymphomas in the 1990s: fact or fancy? Arch Dermatol. 1995;131:603-605.
6. Vonderheid EC, Van Scott EJ, Johnson WC, Grekin DA, Asbell SO. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results. Arch Dermatol. 1977;113:454-462.
7. Volden G, Molan L, Thomsen K. PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides. BMJ. 1978;876:865-866.
8. Leshaw S, Simon RS, Baer RL, Failure to induce tolerance to mechlorethamine hydrochloride. Arch Dermatol. 1977;113:1406-1408.
9. Monk BE, Vollum DI, du Vivier AW, Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides. Clin Exp Dermatol. 1984;9:243-247.
10. Pariser DM, Childrers RC, Kechijian P, Halprin KM, Taylor JR. Intravenous desensitization to mechlorethamine in patients with psoriasis. Arch Dermatol. 1976; 112:1113-1114.
11. Nusbaum BP, Edwards EK, Horwitz SN, Frost P. Psoriasis therapy: the effect of UV radiation on sensitization to mechlorethamine. Arch Dermatol. 1983;119:117-121.
12. Halprin KM, Comeford M, Presser SE, Taylor JR. Ultraviolet light treatment delays contact sensitization to nitrogen mustard. Br J Dermatol. 1981;105: 71-76.
13. Waldorf DS, Haynes HA, Van Scott EJ. Cutaneous hypersentitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma. Ann Intern Med. 1967;67:283-290.
14. Avril MF. La caryolysine locale. Ann Dermatol Venereol. 1987:114:133-141.
15. Constantine VS, Fuks ZY, Farber EM. Mechlorethamine desensitization in therapy for mycosis fungoides: topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity. Arch Dermatol. 1975;111:484-488.
16. Vonderheid EC, Tan TT, Kantor AF, Shrager L, Micaily B, Van Scott EJ. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol. 1989; 20:416-428.
17. Adams RM, Fisher T. Diagnostic patch testing. In: Adams RM, ed. Occupational Skin Diseases. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990:223-253.
18. Price NM, Hoppe RT, Deneau DG. Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer. 1983;52:2214-2219.
19. Vonderheid EC. Topical mechlorethamine chemotherapy: considerations on its use in mycosis fungoides. Int J Dermatol. 1984;23:180-186.
20. Price NM, Deneau DG, Hoppe RT. The treatment of mycosis fungoides with ointment-based mechlorethamine. Arch Dermatol. 1982;118:234-237.
21. 2 by desensitization and by induction of specific immunologic tolerance Cancer. 1973;32:18-30.
22. Price NM. Topical mechlorethamine: cutaneous changes in patients with mycosis fungoides after its administration. Arch Dermatol. 1977;113:1387-1389.
23. Daughters D, Zackheim H, Maibach H. Urticaria and anaphylactoid reactions after topical applications of mechlorethamine. Arch Dermatol. 1973;107:429-430.
24. Newman JM, Rindler JM, Bergfeld WF, Brydon JK, Stevens-Johnson syndrome associated with topical nitrogen mustard therapy. J Am Acad Dermatol. 1997; 36:112-114.
25. Van Scott EJ. Yu RJ. Antimitotic, antigenic, and structural relationships of nitrogen mustard and its homologues. J Invest Dermatol. 1974;62:378-383.
26. Cordonnier J. Lettre de la direction de la pharmacie et du medicament a propos des preparations magistrales de pommade a base de mechlorethamine. Ann Dermatol Venereol. 1985;112:293.